|
|||||
|
|
Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network |
|
| Authors: | Raiker Rahul Pakhchanian Haig Kavadichanda Chengappa Gupta Latika Kardeş Sinan Ahmed Sakir |
| Affiliation: | 1.West Virginia University School of Medicine, Morgantown, WV, USA ;2.George Washington University School of Medicine & Health Sciences, Washington, DC, USA ;3.Department of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India ;4.Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI), Lucknow, Uttar Pradesh, India ;5.Department of Medical Ecology and Hydroclimatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey ;6.Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences (KIMS), KIIT University, Bhubaneswar, India, 751024 ; |
| Abstract: | Clinical Rheumatology - The outcomes of COVID-19 in patients with axial spondyloarthritis (ax-SpA) have not been explored in detail. Tumour necrosis factor inhibitors (TNFi) are commonly used for... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |